Cannabinoid receptors as novel _targets for the treatment of melanoma
- PMID: 17065222
- DOI: 10.1096/fj.06-6638fje
Cannabinoid receptors as novel _targets for the treatment of melanoma
Abstract
Melanoma causes the greatest number of skin cancer-related deaths worldwide. Despite intensive research, prevention and early detection are the only effective measures against melanoma, so new therapeutic strategies are necessary for the management of this devastating disease. Here, we evaluated the efficacy of cannabinoid receptor agonists, a new family of potential antitumoral compounds, at skin melanoma. Human melanomas and melanoma cell lines express CB1 and CB2 cannabinoid receptors. Activation of these receptors decreased growth, proliferation, angiogenesis and metastasis, and increased apoptosis, of melanomas in mice. Cannabinoid antimelanoma activity was independent of the immune status of the animal, could be achieved without overt psychoactive effects and was selective for melanoma cells vs. normal melanocytes. Cannabinoid antiproliferative action on melanoma cells was due, at least in part, to cell cycle arrest at the G1-S transition via inhibition of the prosurvival protein Akt and hypophosphorylation of the pRb retinoblastoma protein tumor suppressor. These findings may contribute to the design of new chemotherapeutic strategies for the management of melanoma.
Similar articles
-
Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.Clin Cancer Res. 2008 Dec 1;14(23):7691-700. doi: 10.1158/1078-0432.CCR-08-0799. Clin Cancer Res. 2008. PMID: 19047095
-
Cannabinoid receptors in conjunctival epithelium: identification and functional properties.Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4535-44. doi: 10.1167/iovs.07-1319. Epub 2008 Jun 19. Invest Ophthalmol Vis Sci. 2008. PMID: 18566465
-
Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.J Pharmacol Exp Ther. 2006 May;317(2):820-9. doi: 10.1124/jpet.105.100503. Epub 2006 Jan 25. J Pharmacol Exp Ther. 2006. PMID: 16436496
-
Therapeutic potential of cannabinoid receptor ligands: current status.Methods Find Exp Clin Pharmacol. 2006 Apr;28(3):177-83. doi: 10.1358/mf.2006.28.3.985231. Methods Find Exp Clin Pharmacol. 2006. PMID: 16810344 Review.
-
Cannabinoids for the treatment of inflammation.Curr Opin Investig Drugs. 2007 May;8(5):373-84. Curr Opin Investig Drugs. 2007. PMID: 17520866 Review.
Cited by
-
In the weeds: A comprehensive review of cannabis; its chemical complexity, biosynthesis, and healing abilities.Toxicol Rep. 2024 Jun 29;13:101685. doi: 10.1016/j.toxrep.2024.101685. eCollection 2024 Dec. Toxicol Rep. 2024. PMID: 39056093 Free PMC article. Review.
-
New Insights on Hemp Oil Enriched in Cannabidiol: Decarboxylation, Antioxidant Properties and In Vitro Anticancer Effect.Antioxidants (Basel). 2021 May 7;10(5):738. doi: 10.3390/antiox10050738. Antioxidants (Basel). 2021. PMID: 34067035 Free PMC article.
-
Anticancer properties of cannabidiol and Δ9-tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines.J Cannabis Res. 2023 Mar 4;5(1):7. doi: 10.1186/s42238-023-00174-z. J Cannabis Res. 2023. PMID: 36870996 Free PMC article.
-
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer.Biomed Res Int. 2018 Dec 4;2018:1691428. doi: 10.1155/2018/1691428. eCollection 2018. Biomed Res Int. 2018. PMID: 30627539 Free PMC article. Review.
-
Cannabinoids in the Pathophysiology of Skin Inflammation.Molecules. 2020 Feb 4;25(3):652. doi: 10.3390/molecules25030652. Molecules. 2020. PMID: 32033005 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical